No Data
No Data
Express News | Bright Minds Biosciences Brief: Announcing "Positive" QEEG (Quantitative Electroencephalogram) Data From Its First-in-Human Phase 1 Study of Lead Compound, BMB-101
Express News | Bright Minds Biosciences Brief: Announced "Positive" Topline Data for Its First-in-Human Phase 1 Study of Lead Compound, BMB-101
CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)
Toronto, Ontario--(Newsfile Corp. - Le 12 juillet/July 2023) - Bright Minds Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-cons
Bright Minds Announces Effective Date of Share Consolidation
Bright Minds Biosciences Brief: Says Received a "Favorable" Written Opinion From International Searching Authority for BMB-202
06:53 AM EDT, 04/19/2023 (MT Newswires) -- Bright Minds Biosciences Brief: Says Received a "Favorable" Written Opinion from International Searching Authority for BMB-202
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Decreases By 11.6%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 82